ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer

Laura Cato, Jonas de Tribolet-Hardy, Irene Lee, Jaice T. Rottenberg, Ilsa Coleman, Diana Melchers, René Houtman, Tengfei Xiao, Wei Li, Takuma Uo, Shihua Sun, Nane C. Kuznik, Bettina Göppert, Fatma Ozgun, Martin E. van Royen, Adriaan B. Houtsmuller, Raga Vadhi, Prakash K. Rao, Lewyn Li, Steven P. BalkRobert B. Den, Bruce J. Trock, R. Jeffrey Karnes, Robert B. Jenkins, Eric A. Klein, Elai Davicioni, Friederike J. Gruhl, Henry W. Long, X. Shirley Liu, Andrew C.B. Cato, Nathan A. Lack, Peter S. Nelson, Stephen R. Plymate, Anna C. Groner, Myles Brown

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


Cato et al. utilize cistrome and transcriptome analyses in castration-resistant prostate cancer (CRPC) to reveal that the androgen receptor (AR) splice variant ARv7 functions as a transcriptional repressor and heterodimerizes with full-length AR at a subset of growth-suppressive genes to support CRPC growth.

Original languageEnglish (US)
Pages (from-to)401-413.e6
JournalCancer cell
Issue number3
StatePublished - Mar 18 2019


  • AR variant v7 (ARv7)
  • androgen receptor (AR)
  • castration-resistant prostate cancer (CRPC)
  • transcription

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.

Cite this